Literature DB >> 30765486

The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency.

Marc Miravitlles1, Joanna Chorostowska-Wynimko2, Ilaria Ferrarotti3, Noel G McElvaney4, Karen O'Hara5,6, Jan Stolk7, Robert A Stockley8, Alice Turner9, Marion Wilkens6,10, Timm Greulich11.   

Abstract

Entities:  

Year:  2019        PMID: 30765486     DOI: 10.1183/13993003.00138-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  IMpact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration.

Authors:  David G Parr; Joanna Chorostowska-Wynimko; Angelo Corsico; Cristina Esquinas; Gerard N McElvaney; Annelot D Sark; Maria Sucena; Hanan Tanash; Alice M Turner; Marc Miravitlles
Journal:  Arch Bronconeumol       Date:  2022-07-11       Impact factor: 6.333

Review 2.  Clinical considerations in individuals with α1-antitrypsin PI*SZ genotype.

Authors:  Gerard N McElvaney; Robert A Sandhaus; Marc Miravitlles; Gerard M Turino; Niels Seersholm; Marion Wencker; Robert A Stockley
Journal:  Eur Respir J       Date:  2020-06-18       Impact factor: 16.671

3.  Relationship of CT densitometry to lung physiological parameters and health status in alpha-1 antitrypsin deficiency: initial report of a centralised database of the NIHR rare diseases translational research collaborative.

Authors:  Diana Crossley; James Stockley; Charlotte E Bolton; Nicholas S Hopkinson; Ravi Mahadeva; Michael Steiner; Tom Wilkinson; John R Hurst; Bibek Gooptu; Robert A Stockley
Journal:  BMJ Open       Date:  2020-06-30       Impact factor: 2.692

Review 4.  New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.

Authors:  Joanna Chorostowska-Wynimko; Miriam Barrecheguren; Ilaria Ferrarotti; Timm Greulich; Robert A Sandhaus; Michael Campos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-02-12

5.  Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.

Authors:  Timm Greulich; Anna Albert; Werner Cassel; Tobias Boeselt; Erika Peychev; Andreas Klemmer; Francini Ferreira; Christian Clarenbach; Maria L Torres-Duran; Alice M Turner; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-01-05

6.  Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO.

Authors:  María Torres-Durán; José Luis López-Campos; Juan Luis Rodríguez-Hermosa; Cristina Esquinas; Cristina Martínez-González; José María Hernández-Pérez; Carlota Rodríguez; Ana Bustamante; Francisco Casas-Maldonado; Miriam Barrecheguren; Cruz González; Marc Miravitlles
Journal:  ERJ Open Res       Date:  2022-09-26

7.  Protocol for the EARCO Registry: a pan-European observational study in patients with α1-antitrypsin deficiency.

Authors:  Timm Greulich; Alan Altraja; Miriam Barrecheguren; Robert Bals; Jan Chlumsky; Joanna Chorostowska-Wynimko; Christian Clarenbach; Luciano Corda; Angelo Guido Corsico; Ilaria Ferrarotti; Cristina Esquinas; Caroline Gouder; Ana Hećimović; Aleksandra Ilic; Yavor Ivanov; Sabina Janciauskiene; Wim Janssens; Malcolm Kohler; Alvils Krams; Beatriz Lara; Ravi Mahadeva; Gerry McElvaney; Jean-François Mornex; Karen O'Hara; David Parr; Eava Piitulainen; Karin Schmid-Scherzer; Niels Seersholm; Robert A Stockley; Jan Stolk; Maria Sucena; Hanan Tanash; Alice Turner; Ruxandra Ulmeanu; Marion Wilkens; Arzu Yorgancioğlu; Ana Zaharie; Marc Miravitlles
Journal:  ERJ Open Res       Date:  2020-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.